Literature DB >> 26718232

Cause and Long-Term Outcome of Cardiac Tamponade.

Cristina Sánchez-Enrique1, Iván J Nuñez-Gil2, Ana Viana-Tejedor1, Alberto De Agustín1, David Vivas1, Julián Palacios-Rubio1, Jean Paul Vilchez1, Alberto Cecconi1, Carlos Macaya1, Antonio Fernández-Ortiz1.   

Abstract

Cardiac tamponade is a life-threatening condition, whose current specific cause and outcome are unknown. Our purpose was to analyze it. We performed a retrospective observational study with prospective follow-up data including 136 consecutive patients admitted with diagnosis of cardiac tamponade, from 2003 to 2013. We thoroughly recorded variables as clinical features, drainage/pericardiocentesis, fluid characteristics, and long-term events (new cardiac tamponade ± death). The median age was 65 ± 17 years (55% men). In the baseline characteristics, 70% were no smokers, 12% were on anticoagulation, and 13 had suffered a previous myocardial infarction. In the preceding month, 15 patients had undergone a cardiac catheterization, 5 cardiac surgery, and 5 pacemaker insertion. Fever was observed in 16% of patients and 21% displayed other inflammatory symptoms. In 81% of patients, pericardiocentesis was needed. The fluid was hemorrhagic or a transudate in the majority, with positive cytology in 15% and bacteria in 3.7%. Main causes were malignancy (32%), infection (24%), idiopathic (16%), iatrogenic (15%), postmyocardial infarction (7%), uremic (4%), and other causes (2%). After a maximum follow-up of 10.4 years, cardiac tamponade recurred in 10% of the cases (62% in the neoplastic group) and the 48% of patients died (89% in the neoplastic cohort). In conclusion, most cardiac tamponades are due to malignancy, having this specific cause a poorer outcome, probably as a manifestation of an advanced disease. The rest of causes, after an aggressive intensive management, have a good prognosis, especially the iatrogenic.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26718232     DOI: 10.1016/j.amjcard.2015.11.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  The value of the new scoring system for predicting neoplastic pericarditis in the patients with large pericardial effusion.

Authors:  M Szturmowicz; A Pawlak-Cieślik; A Fijałkowska; J Gątarek; A Skoczylas; M Dybowska; K Błasińska-Przerwa; R Langfort; W Tomkowski
Journal:  Support Care Cancer       Date:  2017-03-03       Impact factor: 3.603

2.  A case of cardiac tamponade due to an isolated abscess in the ascending aorta of a pregnant woman with a history of intravenous substance abuse.

Authors:  Brandy Shattuck; John Livingstone
Journal:  Forensic Sci Med Pathol       Date:  2017-03-17       Impact factor: 2.007

3.  Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?

Authors:  Bei-Ning Wang; Yu-Xi Li; Wei Ma; Song-Yun Chu; Zhi-Hao Liu; Wen-Hui Ding; Jian-Ping Li
Journal:  J Geriatr Cardiol       Date:  2020-11-28       Impact factor: 3.327

4.  Causes and prognosis of symptomatic pericardial effusions treated by pericardiocentesis in an Asian academic medical centre.

Authors:  Xian Pei Cheong; Lawrence Ka Peng Law; Swee-Chong Seow; Lik Wui Edgar Tay; Huay Cheem Tan; Wee Tiong Yeo; Adrian F Low; Pipin Kojodjojo
Journal:  Singapore Med J       Date:  2019-07-11       Impact factor: 1.858

Review 5.  Fatal endocarditis with methicilin-sensible Staphylococcus aureus and major complications: rhabdomyolysis, pericarditis, and intracerebral hematoma: A case report and review of the literature.

Authors:  Anca Meda Georgescu; Leonard Azamfirei; Krisztina Szalman; Edit Szekely
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.

Authors:  Alexander Strobbe; Tom Adriaenssens; Johan Bennett; Christophe Dubois; Walter Desmet; Keir McCutcheon; Johan Van Cleemput; Peter R Sinnaeve
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

7.  Pericardial Effusions in Patients With Cancer: Anesthetic Management and Survival Outcomes.

Authors:  Casey M Chai; Kenneth Seier; Kay See Tan; Iris Chu; James M Isbell; Gregory W Fischer; Anoushka M Afonso
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-08-26       Impact factor: 2.628

8.  Ultrasound-assisted diagnosis of intraoperative cardiac tamponade during hemihepatectomy: a case report.

Authors:  Jia-Wan Wang; Ying-Qi Chen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

9.  Pericardiocentesis With Extended Drainage and Colchicine: New Indication for Malignant Pericardial Effusions?

Authors:  Massimo Imazio
Journal:  J Am Coll Cardiol       Date:  2020-09-29       Impact factor: 24.094

10.  Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes.

Authors:  Andrea Pennacchioni; Giulia Nanni; Fabio Alfredo Sgura; Jacopo Francesco Imberti; Daniel Enrique Monopoli; Rosario Rossi; Giuseppe Longo; Salvatore Arrotti; Marco Vitolo; Giuseppe Boriani
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.